GlassScriptPhysician profile
Emily Dehaven Todd
NPI 1487026589
$769.15
in general payments reported to CMS, 2019-2025
13 companies · $40.10 in 2025
The $40.10 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $271 · 2022: $229 · 2023: $165 · 2024: $64.07 · 2025: $40.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $132.78 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.12 | 2022-2025 | Jardiance |
| Medtronic, INC. | $90.00 | 2021 | |
| Boston Scientific Corporation | $87.55 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.83 | 2021 | |
| Shockwave Medical, INC | $49.55 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $47.16 | 2022-2024 | Farxiga |
| Allergan, INC. | $44.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $38.61 | 2024-2025 | |
| Biosense Webster, INC. | $34.58 | 2021 | |
| Abbvie INC. | $29.76 | 2024 | |
| Pfizer INC. | $27.51 | 2023 | |
| Depuy Synthes Sales INC. | $13.53 | 2023 | Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.